Consumer Reports Could Change Its Opinion on Tesla's Model 3
*By Jacqueline Corba*
Consumer Reports magazine [does not recommend](https://www.consumerreports.org/hybrids-evs/tesla-model-3-review-falls-short-of-consumer-reports-recommendation/) Tesla's Model 3, saying the mass-market electric car has big flaws in its braking system. But the magazine's director of automotive testing told Cheddar he would re-evaluate the car after Tesla makes upgrades.
In the magazine's test, it took a Model 3 going 60 miles an hour 152 feet to stop ー 20 feet longer than other cars in its class. "That's not going to help you prevent a crash if you really need to slam on the brakes," said Consumer Reports' director of automotive testing Jake Fisher. "We were very surprised when we saw the distance out of the Model 3."
Fisher said he personally spoke to Tesla's CEO, Elon Musk, on Tuesday night. Musk told him Tesla was looking to put out a fix as soon as the weekend.
Tesla has the ability to re-calibrate its braking system through its software and send updates to cars already on the road.
"If we get the update on our car we are absolutely going to retest that vehicle," said Fisher. "If it really shortens those distances this car very well can be recommended after we do that."
When asked how often Consumer Reports changes its recommendation, Fisher said the magazine is regularly testing and re-testing cars.
For full interview, [click here](https://cheddar.com/videos/consumer-reports-faults-brakes-on-teslas-model-3).
NYC's mayoral race heats up with a socialist candidate aiming to make the city affordable—and rattling the financial sector. Plus: Coinbase's prospects.
A stark disagreement over regulating AI in Republicans’ tax cut and spending bill is the latest tension among conservatives about whether to let states continue to put guardrails on emerging technologies or minimize such interference.
Mark Hamrick of Bankrate discusses the jobs market, AI's growing impact on employment, and how markets are reacting to today’s surprising payroll data.
Amanda Chu of POLITICO reveals how lawmakers are betting millions on pharma stocks even as Trump threatens tariffs and demands steep drug price cuts. Watch!